01.12.2014 | Research article | Ausgabe 1/2014 Open Access

Care planning needs of palliative home care clients: Development of the interRAI palliative care assessment clinical assessment protocols (CAPs)
- Zeitschrift:
- BMC Palliative Care > Ausgabe 1/2014
Electronic supplementary material
Competing interests
Authors’ contributions
Background
Methods
CAP development process
Data source
Clinical assessment protocols (CAPs)
Study sample
Total population % (N)
|
|
---|---|
Age groups
|
|
18-44
|
4.3 (288)
|
45-64
|
29.9 (2,025)
|
65-74
|
25.4 (1,718)
|
75-84
|
28.7 (1,943)
|
85 +
|
11.7 (795)
|
Gender
|
|
Male
|
49.1 (3,303)
|
Female
|
50.9 (3,418)
|
Estimated prognosis
|
|
Greater than 6 months
|
41.5 (2,310)
|
6 weeks to 6 months
|
48.1 (2,677)
|
Less than 6 weeks
|
8.4 (468)
|
Death Imminent
|
2.0 (110)
|
CCAC Site location
|
|
Site 1
|
4.0 (270)
|
Site 2
|
47.7 (4,581)
|
Site 3
|
14.6 (991)
|
Site 4
|
7.5 (510)
|
Site 5
|
2.1 (142)
|
Site 6
|
4.1 (275)
|
Diagnosis
|
|
Have cancer diagnosis
|
86.8 (5,875)
|
Metastatic
|
40.0 (2,710)
|
Not Metastatic
|
46.8 (3,165)
|
Do not have cancer
|
9.8 (666)
|
Diagnosis unspecified
|
3.4 (228)
|
Analysis
Results
Dyspnea
|
Nutrition
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Not triggered % (N)
|
Trigger level 1% (N)
|
Chi-square (df)
|
p Value
|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
|
Age groups
|
|||||||||
18-44
|
68.6 (192)
|
31.4 (88)
|
31.8 (4)
|
<.0001
|
76.4 (155)
|
12.3 (25)
|
11.3 (23)
|
28.4 (8)
|
0.0004
|
45-64
|
57.1 (1,140)
|
42.9 (858)
|
78.7 (1,044)
|
6.3 (84)
|
14.9 (198)
|
||||
65-74
|
54.4 (919)
|
45.6 (769)
|
76.5 (855)
|
8.4 (94)
|
15.1 (169)
|
||||
75-84
|
52.0 (994)
|
48.0 (919)
|
73.1 (882)
|
10.3 (124)
|
16.7 (201)
|
||||
85 +
|
54.0 (420)
|
45.9 (356)
|
71.9 (330)
|
12.2 (56)
|
15.9 (73)
|
||||
Gender
|
|||||||||
Male
|
53.1 (1,727)
|
46.9 (1,526)
|
9.6 (1)
|
0.002
|
78.9 (1,645)
|
6.3 (132)
|
14.8 (308)
|
38.1 (2)
|
<.0001
|
Female
|
56.9 (1,908)
|
43.1 (1,446)
|
72.5 (1,591)
|
11.4 (251)
|
16.1 (353)
|
||||
Estimated prognosis
|
|||||||||
Death imminent
|
37.4 (40)
|
62.6 (67)
|
105.2 (3)
|
<.0001
|
64.7 (33)
|
2.0 (1)
|
33.3 (17)
|
78.4 (6)
|
<.0001
|
Less than 6 weeks
|
43.8 (203)
|
56.3 (261)
|
65.2 (193)
|
6.8 (20)
|
28.0 (83)
|
||||
6 weeks to 6 months
|
53.4 (1,413)
|
46.6 (1,235)
|
73.5 (1,407)
|
9.2 (176)
|
17.3 (331)
|
||||
Greater than 6 months
|
63.7 (1,454)
|
36.3 (829)
|
79.4 (1,355)
|
9.4 (161)
|
11.2 (191)
|
||||
Geographic location
|
|||||||||
Site 1
|
62.6 (167)
|
37.5 (100)
|
41.5 (5)
|
<.0001
|
74.1 (172)
|
4.7 (11)
|
21.1 (49)
|
38.9 (10)
|
<.0001
|
Site 2
|
53.3 (2,389)
|
46.7 (2,091)
|
77.1 (1,945)
|
8.2 (208)
|
14.7 (371)
|
||||
Site 3
|
58.1 (574)
|
41.9 (414)
|
71.3 (627)
|
10.8 (95)
|
17.9 (157)
|
||||
Site 4
|
54.0 (273)
|
46.1 (233)
|
75.6 (272)
|
10.8 (39)
|
13.6 (49)
|
||||
Site 5
|
76.4 (107)
|
23.6 (33)
|
72.8 (75)
|
17.5 (18)
|
9.7 (10)
|
||||
Site 6
|
56.6 (155)
|
43.4 (119)
|
81.4 (175)
|
5.6 (12)
|
13.0 (28)
|
||||
Diagnosis
|
|||||||||
Have cancer diagnosis
|
57.8 (2,295)
|
42.2 (1,678)
|
98.9 (3)
|
<.0001
|
76.1 (1,912)
|
8.71 (219)
|
15.2 (383)
|
39.5 (6)
|
<.0001
|
Have cancer and non-cancer diagnosis
|
56.5 (1,023)
|
43.5 (789)
|
77.8 (1,047)
|
6.76 (91)
|
15.5 (208)
|
||||
Have non-cancer diagnosis only
|
37.8 (245)
|
62.3 (404)
|
67.5 (241)
|
16.8 (60)
|
15.7 (56)
|
||||
Diagnosis unspecified
|
46.2 (103)
|
53.9 (119)
|
68.8 (66)
|
13.5 (13)
|
17.7 (17)
|
Pain
|
Pressure ulcers
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
|
Age groups
|
||||||||||
18-44
|
47.4 (120)
|
20.6 (52)
|
32.0 (81)
|
156.7 (8)
|
<.0001
|
91.2 (239)
|
5.34 (14)
|
3.4 (9)
|
87.8 (8)
|
<.0001
|
45-64
|
51.9 (955)
|
23.1 (425)
|
25.0 (460)
|
91.6 (1,708)
|
3.9 (73)
|
4.5 (84)
|
||||
65-74
|
59.9 (948)
|
21.2 (336)
|
18.8 (298)
|
89.4 (1,414)
|
5.6 (88)
|
5.1 (80)
|
||||
75-84
|
67.4 (1,191)
|
16.2 (286)
|
16.3 (288)
|
88.3 (1,573)
|
8.0 (143)
|
3.7 (66)
|
||||
85 +
|
70.8 (499)
|
16.1 (113)
|
13.1 (92)
|
83.3 (600)
|
13.3 (96)
|
3.3 (24)
|
||||
Gender
|
||||||||||
Male
|
59.5 (1,775)
|
19.9 (593)
|
20.6 (614)
|
2.8 (2)
|
0.25
|
88.6 (2,684)
|
6.7 (204)
|
4.7 (141)
|
2.7 (2)
|
0.26
|
Female
|
61.4 (1,913)
|
19.5 (608)
|
19.1 (594)
|
89.6 (2,811)
|
6.6 (208)
|
3.8 (120)
|
||||
Estimated prognosis
|
||||||||||
Death imminent
|
51.5 (51)
|
24.2 (24)
|
24.2 (24)
|
53.2 (6)
|
<.0001
|
76.0 (73)
|
22.9 (22)
|
1.0 (1)
|
139.4 (6)
|
<.0001
|
Less than 6 weeks
|
50.5 (218)
|
23.6 (102)
|
25.9 (112)
|
80.0 (348)
|
15.9 (69)
|
4.1 (18)
|
||||
6 weeks to 6 months
|
57.3 (1,454)
|
22.1 (562)
|
20.6 (522)
|
87.9 (2,222)
|
7.5 (190)
|
4.6 (115)
|
||||
Greater than 6 months
|
65.2 (1,424)
|
18.2 (398)
|
16.6 (363)
|
92.7 (2,022)
|
3.5 (76)
|
3.8 (83)
|
||||
Geographic location
|
||||||||||
Site 1
|
50.2 (133)
|
23.8 (63)
|
26.1 (69)
|
195.2 (10)
|
<.0001
|
87.6 (232)
|
7.9 (21)
|
4.5 (12)
|
34.7 (10)
|
0.0001
|
Site 2
|
59.3 (2,382)
|
20.9 (838)
|
19.8 (795)
|
89.5 (3,653)
|
6.1 (248)
|
4.4 (181)
|
||||
Site 3
|
77.1 (745)
|
10.0 (97)
|
12.9 (125)
|
87.5 (853)
|
9.6 (94)
|
2.9 (28)
|
||||
Site 4
|
48.9 (244)
|
20.0 (100)
|
31.1 (155)
|
87.8 (430)
|
5.7 (28)
|
6.5 (32)
|
||||
Site 5
|
58.4 (80)
|
24.8 (34)
|
16.8 (23)
|
88.2 (119)
|
8.9 (12)
|
3.0 (4)
|
||||
Site 6
|
49.4 (129)
|
30.7 (80)
|
19.9 (52)
|
93.6 (247)
|
4.2 (11)
|
2.3 (6)
|
||||
Diagnosis
|
||||||||||
Have cancer diagnosis
|
57.9 (2,124)
|
21.1 (774)
|
21.0 (772)
|
56.3 (6)
|
<.0001
|
91.0 (3,375)
|
4.5 (166)
|
4.6 (169)
|
215.9 (6)
|
<.0001
|
Have cancer & non-cancer diagnosis
|
61.7 (1,044)
|
18.5 (313)
|
19.8 (335)
|
90.0 (1,541)
|
6.3 (108)
|
3.7 (64)
|
||||
Have Non-cancer diagnosis only
|
73.2 (429)
|
13.0 (76)
|
13.8 (81)
|
75.6 (445)
|
20.5 (121)
|
3.9 (23)
|
||||
Diagnosis unspecified
|
59.2 (116)
|
25.0 (49)
|
15.8 (31)
|
86.9 (173)
|
9.6 (19)
|
3.5 (7)
|
Fatigue
|
Sleep disturbance
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
|
Age groups
|
||||||||||
18-44
|
31 (62)
|
40.0 (80)
|
29.0 (58)
|
23.2 (8)
|
0.003
|
62.8 (135)
|
12.1 (26)
|
25.1 (54)
|
74.7 (8)
|
<.0001
|
45-64
|
26.3 (396)
|
36.3 (547)
|
37.4 (564)
|
66.2 (1,055)
|
12.1 (192)
|
21.7 (346)
|
||||
65-74
|
27.5 (351)
|
31.8 (406)
|
40.7 (520)
|
73.6 (1,015)
|
11.5 (159)
|
14.9 (206)
|
||||
75-84
|
25.7 (364)
|
34.4 (487)
|
39.9 (565)
|
76.8 (1,187)
|
10.0 (154)
|
13.3 (205)
|
||||
85 +
|
24.5 (136)
|
30.6 (170)
|
44.9 (249)
|
74.5 (462)
|
13.1 (81)
|
12.4 (77)
|
||||
Gender
|
||||||||||
Male
|
25.3 (607)
|
33.9 (815)
|
40.9 (982)
|
4.7 (2)
|
0.09
|
69.5 (1,813)
|
13.3 (346)
|
17.2 (449)
|
20.2 (2)
|
<.0001
|
Female
|
27.6 (693)
|
34.2 (860)
|
38.2 (960)
|
74.3 (2,014)
|
9.7 (263)
|
16.0 (433)
|
||||
Estimated prognosis
|
||||||||||
Death imminent
|
2.5 (2)
|
8.9 (7)
|
88.6 (70)
|
856.8 (6)
|
<.0001
|
68.8 (53)
|
9.1 (7)
|
22.1 (17)
|
23.1 (6)
|
0.0008
|
Less than 6 weeks
|
3.8 (15)
|
25.3 (99)
|
70.8 (277)
|
75.3 (289)
|
5.0 (19)
|
19.8 (76)
|
||||
6 weeks to 6 months
|
14.1 (337)
|
41.9 (1,000)
|
44.0 (1,052)
|
71.5 (1,635)
|
11.2 (257)
|
17.3 (394)
|
||||
Greater than 6 months
|
45.6 (955)
|
27.9 (584)
|
26.6 (557)
|
72.0 (1,483)
|
12.5 (258)
|
15.5 (320)
|
||||
Geographic location
|
||||||||||
Site 1
|
19.5 (50)
|
35.2 (90)
|
45.3 (116)
|
202.3 (10)
|
<.0001
|
76.5 (199)
|
6.9 (18)
|
16.5 (43)
|
31.6 (10)
|
0.0005
|
Site 2
|
28.9 (868)
|
28.7 (860)
|
42.4 (1,273)
|
73.1 (2,499)
|
11.5 (393)
|
15.5 (529)
|
||||
Site 3
|
28.5 (262)
|
45.1 (415)
|
26.5 (244)
|
67.1 (633)
|
13.8 (130)
|
19.09 (180)
|
||||
Site 4
|
15.8 (70)
|
40.3 (178)
|
43.9 (194)
|
70.8 (312)
|
7.9 (35)
|
21.32 (94)
|
||||
Site 5
|
18.0 (20)
|
64.0 (71)
|
18.0 (20)
|
73.9 (68)
|
12.0 (11)
|
14.13 (13)
|
||||
Site 6
|
17.4 (39)
|
33.9 (76)
|
48.7 (109)
|
72.6 (143)
|
12.7 (25)
|
14.72 (29)
|
||||
Diagnosis
|
||||||||||
Have cancer diagnosis
|
28.1 (823)
|
34.7 (1,016)
|
37.2 (1,090)
|
94.2 (6)
|
<.0001
|
73.6 (2,360)
|
11.3 (362)
|
15.1 (484)
|
19.8 (6)
|
0.003
|
Have cancer and non-cancer diagnosis
|
26.2 (375)
|
37.1 (530)
|
36.7 (525)
|
68.8 (1,038)
|
11.9 (180)
|
19.28 (291)
|
||||
Have non-cancer diagnosis only
|
17.2 (79)
|
24.8 (114)
|
58.0 (266)
|
71.2 (349)
|
9.8 (48)
|
18.98 (93)
|
||||
Diagnosis unspecified
|
23.4 (32)
|
21.9 (30)
|
54.7 (75)
|
71.8 (107)
|
14.8 (22)
|
13.4 (20)
|
Delirium
|
Mood disturbance
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Not triggered % (N)
|
Trigger level 1% (N)
|
Chi-square (df)
|
p Value
|
Not triggered % (N)
|
Trigger level 1% (N)
|
Trigger level 2% (N)
|
Chi-square (df)
|
p Value
|
|
Age groups
|
|||||||||
18-44
|
91.3 (240)
|
8.8 (23)
|
12.9 (8)
|
0.02
|
63.4 (156)
|
14.2 (35)
|
22.4 (55)
|
45.2 (8)
|
<.0001
|
45-64
|
86.8 (1,601)
|
13.2 (244)
|
61.4 (1,105)
|
17.5 (315)
|
21.2 (381)
|
||||
65-74
|
86.1 (1,348)
|
13.9 (217)
|
63.8 (953)
|
18.0 (269)
|
18.2 (272)
|
||||
75-84
|
87.1 (1,540)
|
12.9 (228)
|
68.1 (1,161)
|
16.2 (276)
|
15.7 (267)
|
||||
85 +
|
83.1 (580)
|
16.9 (118)
|
71.7 (492)
|
16.0 (110)
|
12.2 (84)
|
||||
Gender
|
|||||||||
Male
|
86.0 (2,567)
|
14.0 (417)
|
1.3 (2)
|
0.25
|
66.1 (1,904)
|
16.6 (479)
|
17.2 (496)
|
2.2 (2)
|
0.33
|
Female
|
87.0 (2,706)
|
13.0 (403)
|
64.3 (1,933)
|
17.4 (522)
|
18.3 (551)
|
||||
Estimated prognosis
|
|||||||||
Death Imminent
|
30.5 (25)
|
69.5 (57)
|
510.5 (6)
|
<.0001
|
65.1 (54)
|
19.3 (16)
|
15.7 (13)
|
73.3 (6)
|
<.0001
|
Less than 6 weeks
|
62.1 (267)
|
37.9 (163)
|
51.3 (205)
|
18.5 (74)
|
30.3 (121)
|
||||
6 weeks to 6 months
|
85.5 (2,171)
|
14.5 (368)
|
62.1 (1,492)
|
18.3 (440)
|
19.6 (470)
|
||||
Greater than 6 months
|
93.3 (2,036)
|
6.7 (146)
|
69.6 (1,490)
|
15.3 (328)
|
15.1 (324)
|
||||
Geographic location
|
|||||||||
Site 1
|
79.6 (214)
|
20.5 (55)
|
85.1 (10)
|
<.0001
|
62.3 (167)
|
15.3 (41)
|
22.4 (60)
|
34.9 (10)
|
0.0001
|
Site 2
|
89.1 (3,560)
|
10.9 (437)
|
66.9 (2,666)
|
17.2 (684)
|
16.0 (638)
|
||||
Site 3
|
81.6 (791)
|
18.5 (179)
|
62.0 (591)
|
15.3 (146)
|
22.8 (217)
|
||||
Site 4
|
80.9 (402)
|
19.1 (95)
|
62.9 (251)
|
18.3 (73)
|
18.8 (75)
|
||||
Site 5
|
93.6 (131)
|
6.4 (9)
|
61.1 (58)
|
17.9 (17)
|
21.1 (20)
|
||||
Site 6
|
79.3 (211)
|
20.7 (55)
|
59.0 (134)
|
19.4 (44)
|
21.6 (49)
|
||||
Diagnosis
|
|||||||||
Have cancer diagnosis
|
88.0 (3,221)
|
12.0 (438)
|
42.5 (6)
|
<.0001
|
66.8 (2,336)
|
16.2 (566)
|
17.0 (595)
|
31.4 (6)
|
<.0001
|
Have cancer and non-cancer diagnosis
|
86.0 (1,482)
|
14.0 (241)
|
60.5 (1,017)
|
18.4 (309)
|
21.1 (355)
|
||||
Have non-cancer diagnosis only
|
78.1 (449)
|
21.9 (126)
|
67.5 (382)
|
18.7 (106)
|
13.8 (78)
|
||||
Diagnosis unspecified
|
86.3 (157)
|
13.7 (25)
|
70.6 (132)
|
12.8 (24)
|
16.6 (31)
|